Right kidney weight

Tags: Physiology · Weight

13 loci · 31 genes with independent associations · 613 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr1	169849415	171245521	1	1	1.61e-07	2.08e-07	3.05e-01	Plekha7
2	chr1	254740406	257369670	8	1	6.67e-08	4.29e-08	1.00e+00	Casp7
3	chr1	257860954	260518987	20	4	2.57e-13	7.82e-14	NaN	Dennd10 Emx2os Prlhr Sfxn4
4	chr3	106026655	107425626	1	1	7.69e-08	9.54e-06	2.72e-01	Itpka
5	chr7	109930926	119313462	494	9	6.64e-14	8.02e-13	NaN	Csdc2 Cyp2d4 Parvb Parvg Ppara Tafa5 Ttll1 Xrcc6
6	chr7	119468026	121470693	12	1	1.38e-07	1.48e-07	1.00e+00	Ppp6r2
7	chr8	108585012	109845634	1	1	7.41e-08	7.54e-03	1.00e+00	Klhdc8b
8	chr9	75969545	77365260	1	1	7.43e-35	1.14e-01	1.00e+00	Zfand2b
9	chr9	107300697	108434469	1	1	3.27e-08	7.83e-10	3.30e-03	Arhgap28
10	chr12	22091	7325669	69	8	4.58e-10	1.20e-08	1.00e+00	Elavl1 Fry Insr Katnal1 LOC102549494 Mcoln1 Slc7a1 Snapc2
11	chr19	32676171	34074113	1	1	1.90e-09	1.07e-04	2.08e-05	Zdhhc1
12	chr19	36759451	38369918	3	1	2.39e-08	1.13e-08	1.47e-02	Ist1
13	chr20	53722628	54429288	1	1	2.70e-09	1.96e-01	1.00e+00	LOC103694460

Pleiotropic Associations

Trait	Chi² ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	Corr	Corr P	Genes
BMI with tail	24.77	28	18	58.1	0.96	9.15e-44	Cacul1 Casp7 Ces2c Dennd10 Emx2os Fam204a Grk5 Klhdc8b Lmf2 LOC102549998 LOC102550729 LOC103694460 LOC120100064 LOC120100068 Mapk11 Nanos1 Plekha7 Plxnb2 Ppp6r2 Prdx3 Prlhr Rab11fip2 Selenoo Sfxn4 Tafa5 Tymp Zfand2b Zfp950
BMI without tail	20.81	16	15	48.4	0.88	9.23e-20	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Klhdc8b LOC102550729 Nanos1 Plekha7 Prdx3 Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Body weight	19.53	50	43	138.7	0.98	5.35e-131	Ablim1 Afap1l2 Atrnl1 Brca2 Cacul1 Casp7 Cers4 Ces2c Dennd10 Elavl1 Emx2os Fam204a Fry Grk5 Hmgb1 Hsph1 Insr Katnal1 Klhdc8b LOC102548389 LOC102549089 LOC102549494 LOC102550729 LOC102553253 LOC103694460 LOC108352411 LOC120095830 LOC120095871 LOC120100064 LOC120100068 Mcoln1 Medag N4bp2l1 N4bp2l2 Nanos1 Pet100 Plekha7 Prdx3 Prlhr Rab11fip2 Rxfp2 Sfxn4 Slc7a1 Snapc2 Stard13 Stxbp2 Tafa5 Trub1 Xab2 Zfp950
Epididymis fat weight	32.47	21	15	48.4	0.87	1.05e-21	Ablim1 Afap1l2 Atrnl1 Cacul1 Casp7 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 LOC120100064 LOC120100068 Nanos1 Prdx3 Prlhr Rab11fip2 Sfxn4 Trub1 Zfand2b Zfp950
Heart weight	22.96	5	1	3.2	0.99	5.14e-05	Cacul1 Emx2os Klhdc8b Sfxn4 Zfand2b
Left kidney weight	13.88	155	136	438.7	1	0.00e+00	A4galt Ankrd54 Arfgap3 Arhgap8 Atrnl1 Atxn10 Baiap2l2 Bik Brca2 Cacna1i Cacul1 Casp7 Cbx7 Cby1 Ccdc134 Cdpf1 Celsr1 Cenpm Cerk Cers4 Ces2c Csdc2 Cyb5r3 Cyp2d1 Cyp2d3 Cyp2d4 Cyp2d5 Dennd10 Desi1 Efcab6 Elavl1 Emx2os Fam118a Fam204a Fbln1 Fry Gramd4 Grap2 Grk5 Gtse1 Hmgb1 Hsph1 Insr Ist1 Itpka Josd1 Katnal1 Klhdc8b L3mbtl2 LOC100362109 LOC102547313 LOC102548389 LOC102549089 LOC102549144 LOC102549494 LOC102549885 LOC102550729 LOC102553253 LOC102554082 LOC103692950 LOC103694460 LOC108351520 LOC108352411 LOC120093690 LOC120093696 LOC120093702 LOC120093706 LOC120095830 LOC120095871 LOC120100064 LOC120100068 Mcat Mchr1 Mcoln1 Medag Mei1 Mgat3 Mief1 Mpped1 Mrtfa N4bp2l1 N4bp2l2 Nanos1 Ndufa6 Ndufb11b Nfam1 Nptxr Nup50 Pacsin2 Parvb Parvg Pet100 Pheta2 Phf21b Phf5a Pick1 Plekha7 Pmfbp1 Pmm1 Pnpla3 Poldip3 Polr3h Ppara Prdx3 Prlhr Prr5 Rab11fip2 Rbx1 RGD1304694 RGD1359634 Rrp7a Rxfp2 Samm50 Scube1 Septin3 Serhl2 Sfxn4 Shisa8 Shisal1 Slc16a8 Slc25a17 Smdt1 Smim45 Snapc2 Snu13 Srebf2 St13 Stard13 Stxbp2 Sult4a1 Sun2 Syngr1 Tab1 Tafa5 Tbc1d22a Tcf20 Tef Tmem184b Tnrc6b Tob2 Trmu Tspo Ttc38 Ttll1 Ttll12 Ube2s-ps3 Wbp2nl Wnt7b Xab2 Xpnpep3 Xrcc6 Zc3h7b Zdhhc1 Zfand2b Zfp950
Tail length	10.99	18	15	48.4	0.77	7.85e-15	Brca2 Cers4 Elavl1 Insr Katnal1 Klhdc8b LOC102548389 LOC102549089 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Snapc2 Stard13 Stxbp2 Xab2 Zfand2b
Length with tail	16.43	30	25	80.6	0.94	1.96e-50	Brca2 Cacul1 Cers4 Elavl1 Fry Hmgb1 Hsph1 Insr Katnal1 Klhdc8b LOC102548389 LOC102549089 LOC102549494 LOC102553253 LOC108352411 LOC120095830 LOC120095871 Mcoln1 Medag N4bp2l1 N4bp2l2 Pet100 Rxfp2 Sfxn4 Slc7a1 Snapc2 Stard13 Stxbp2 Xab2 Zfand2b
Length without tail	14.33	30	20	64.5	0.99	1.56e-90	Brca2 Cacul1 Cers4 Elavl1 Emx2os Fry Grk5 Hmgb1 Hsph1 Insr Katnal1 LOC102548389 LOC102549089 LOC102549494 LOC102553253 LOC108352411 LOC120095830 LOC120095871 Mcoln1 Medag N4bp2l1 N4bp2l2 Pet100 Prlhr Rxfp2 Snapc2 Stard13 Stxbp2 Xab2 Zfand2b
Liver weight, left	11.62	4	0	0	0.61	3.95e-01	Cacul1 Grk5 Klhdc8b Prlhr
Liver weight, right	15.12	13	7	22.6	0.82	1.99e-06	Cacul1 Dennd10 Fam204a Grk5 LOC102549494 LOC103694460 LOC120095830 Prlhr Rab11fip2 Rxfp2 Sfxn4 Zfand2b Zfp950
Parametrial fat weight	23.42	16	13	41.9	0.97	1.86e-36	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Plekha7 Prdx3 Prlhr Rab11fip2 Sfxn4 Zdhhc1 Zfand2b Zfp950
Retroperitoneal fat weight	22.61	48	24	77.4	0.88	4.85e-43	Ablim1 Afap1l2 Atrnl1 Cacna1i Cacul1 Casp7 Cbx7 Cby1 Ces2c Csdc2 Dennd10 Desi1 Emx2os Fam204a Grap2 Grk5 Josd1 Klhdc8b LOC102549144 LOC102550729 LOC103692950 LOC103694460 LOC120093690 LOC120093696 LOC120100064 LOC120100068 Mei1 Mgat3 Nanos1 Nptxr Pmm1 Polr3h Prdx3 Prlhr Rab11fip2 Rbx1 Sfxn4 Slc25a17 Snu13 Sun2 Syngr1 Tab1 Tnrc6b Trub1 Xpnpep3 Zc3h7b Zfand2b Zfp950
Intraocular pressure	38.04	2	2	6.5	0	1.00e+00	LOC103694460 Zfand2b
Extensor digitorum longus weight	6.11	19	5	16.1	1	2.64e-77	Brca2 Cers4 Elavl1 Fry Insr LOC102548389 LOC102549089 LOC102549494 LOC103694460 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Rxfp2 Snapc2 Stard13 Stxbp2 Xab2
Soleus weight	6.36	9	0	0	1	1.87e-11	Ablim1 Afap1l2 Atrnl1 Emx2os Grk5 Klhdc8b LOC120100064 LOC120100068 Trub1
Tibialis anterior weight	8.03	19	14	45.2	1	1.57e-77	Brca2 Cers4 Elavl1 Fry Insr LOC102548389 LOC102549089 LOC102549494 LOC103694460 LOC120095871 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Rxfp2 Snapc2 Stard13 Stxbp2 Xab2
Tibia length	6.87	13	1	3.2	1	3.15e-37	Brca2 Elavl1 Insr Klhdc8b LOC102549494 Mcoln1 N4bp2l1 N4bp2l2 Pet100 Rxfp2 Snapc2 Stard13 Stxbp2
Number of licking bursts	28.51	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Food consumed during 24 hour testing period	15.78	1	0	0	0	1.00e+00	Zfand2b
Mean num. licks in bursts	18.13	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	34.33	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging indifference point 0 sec	12.38	2	0	0	0	1.00e+00	LOC103694460 Zfand2b
Patch foraging indifference point AUC	24.2	1	1	3.2	0	1.00e+00	Zfand2b
Indifference point function ln k	45.4	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Indifference point function log k	45.4	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 0 sec	18.06	2	1	3.2	0	1.00e+00	LOC103694460 Zfand2b
Patch foraging total patch changes 18 sec	48.28	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 24 sec	77.61	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging total patch changes 6 sec	24.67	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging time to switch 0 sec	33.47	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging water rate 0 sec	39.47	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	3.2	0	1.00e+00	Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	35.43	1	1	3.2	0	1.00e+00	Zfand2b
Locomotor activity	35.08	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing distance	55.86	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing rearing	99.51	1	1	3.2	0	1.00e+00	Zfand2b
Light reinforcement 1	14.51	2	1	3.2	0	1.00e+00	Zdhhc1 Zfand2b
Reaction time number correct	66.72	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean minus median	179.03	1	1	3.2	0	1.00e+00	Zfand2b
Reaction time mean minus median AUC	232.47	1	1	3.2	0	1.00e+00	Zfand2b
Reaction time num false alarms AUC	27.43	1	1	3.2	0	1.00e+00	Zfand2b
Reaction time trials correct on left	66.72	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials on left	63.1	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean	30.14	2	2	6.5	0	1.00e+00	Zdhhc1 Zfand2b
Reaction time mean AUC	26.7	2	1	3.2	0	1.00e+00	Zdhhc1 Zfand2b
Median of all reaction times	22.05	2	1	3.2	0	1.00e+00	Zdhhc1 Zfand2b
Reaction time omissions	35.15	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Reaction time false alarm rate	20.24	1	1	3.2	0	1.00e+00	Klhdc8b
Reaction time premature initiations	41.6	1	1	3.2	0	1.00e+00	Zfand2b
Std. dev. reaction times	72.92	1	1	3.2	0	1.00e+00	Zfand2b
Reaction time trials completed	63.1	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials AUC	64.7	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	28.4	1	1	3.2	0	1.00e+00	Klhdc8b
Cocaine response after cond. not corrected	16.6	1	0	0	0	1.00e+00	Klhdc8b
Cocaine response before conditioning	38.66	1	1	3.2	0	1.00e+00	Klhdc8b
Pavlov. Cond. index score	15.43	1	0	0	0	1.00e+00	LOC103694460
Pavlov. Cond. magazine entry number	25.13	2	1	3.2	0	1.00e+00	Klhdc8b LOC103694460
Pavlov. Cond. response bias	13.13	1	0	0	0	1.00e+00	LOC103694460
Conditioned reinforcement - actives	152.54	1	1	3.2	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	76.2	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	3.2	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	3.2	0	1.00e+00	Zfand2b
Intermitt. access day 1 inactive lever presses	169.63	1	1	3.2	0	1.00e+00	Zfand2b
Intermitt. access day 15 inactive lever presses	162.52	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 1 total infusions	71.42	1	1	3.2	0	1.00e+00	Zfand2b
Intermittent access day 15 total infusions	35.39	1	1	3.2	0	1.00e+00	Zfand2b
Intermittent access terminal intake (last 3 days)	24.92	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access total infusions	15.45	1	0	0	0	1.00e+00	Klhdc8b
Intermittent access day 1 locomotion	26.47	1	1	3.2	0	1.00e+00	Zfand2b
Intermittent access day 15 total locomotion	93.08	1	1	3.2	0	1.00e+00	Zfand2b
Intermittent access standard deviation	229.66	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Cocaine induced anxiety	125.35	1	1	3.2	0	1.00e+00	Zfand2b
Baseline Anxiety	393.92	1	1	3.2	0	1.00e+00	Zfand2b
Incentive Sensitization - Responses	169.87	2	2	6.5	0	1.00e+00	Zdhhc1 Zfand2b
Incentive Sensitization - Breakpoint	165.51	2	2	6.5	0	1.00e+00	Zdhhc1 Zfand2b
Progressive ratio test 1 active lever presses	26.41	1	1	3.2	0	1.00e+00	Zfand2b
Progressive ratio test 1 breakpoint	19.19	1	0	0	0	1.00e+00	Zfand2b
Progressive ratio test 1 inactive lever presses	16.55	1	0	0	0	1.00e+00	Klhdc8b
Progressive ratio test 2 active lever presses	67.87	2	2	6.5	0	1.00e+00	Zdhhc1 Zfand2b
Progressive ratio test 2 breakpoint	63.74	2	1	3.2	0	1.00e+00	Zdhhc1 Zfand2b
Progressive ratio test 2 inactive lever presses	63.47	1	1	3.2	0	1.00e+00	Zfand2b
Total sessions with >9 infusions	32.12	2	1	3.2	0	1.00e+00	Klhdc8b Zdhhc1
Short access day 1 total inactive lever presses	21.93	1	0	0	0	1.00e+00	Zfand2b
Short access day 10 total inactive lever presses	72.35	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Short access day 1 total infusions	19.14	1	0	0	0	1.00e+00	Zdhhc1
Short access day 1 locomotion	129.19	1	1	3.2	0	1.00e+00	Zfand2b
Short access day 10 total locomotion	432.47	1	1	3.2	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	3.2	0	1.00e+00	Zfand2b
Compulsive drug intake	68.39	1	1	3.2	0	1.00e+00	Zfand2b
One hour access (0.3 mA shock)	22.58	1	0	0	0	1.00e+00	Zfand2b
One hour access (shock baseline)	14.65	1	0	0	0	1.00e+00	Zdhhc1
Number of responses in last shaping day	67.75	1	1	3.2	0	1.00e+00	Zfand2b
Locomotion distance, session 1	23.98	1	1	3.2	0	1.00e+00	Klhdc8b
Locomotion distance, session 2	33.15	1	1	3.2	0	1.00e+00	Klhdc8b
Locomotion velocity, session 3	17.14	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 8	52.78	1	1	3.2	0	1.00e+00	Klhdc8b
Degree of sensitization distance	24.75	1	0	0	0	1.00e+00	Klhdc8b
Condit. Reinf. active minus inactive responses	35.59	1	1	3.2	0	1.00e+00	Klhdc8b
Condit. Reinf. active-inactive response ratio	25.6	1	1	3.2	0	1.00e+00	Klhdc8b
Condit. Reinf. active responses	18.23	1	0	0	0	1.00e+00	Klhdc8b
Incentive salience index mean	26.23	1	1	3.2	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 1	63.49	1	1	3.2	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 1	37.38	1	1	3.2	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 2	27.1	1	1	3.2	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 2	69.58	1	1	3.2	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 2	19.2	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 2	21.15	1	1	3.2	0	1.00e+00	Klhdc8b
Novel to familiar place preference ratio	22.33	1	0	0	0	1.00e+00	Klhdc8b
Novelty place preference	20.99	1	0	0	0	1.00e+00	Klhdc8b
Time in novel zone, NPP test	17.06	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, NPP test	106.24	1	1	3.2	0	1.00e+00	Klhdc8b
Total locomotion distance, NPP test	47.64	1	1	3.2	0	1.00e+00	Klhdc8b
Locomotion velocity, NPP test	51.12	1	1	3.2	0	1.00e+00	Klhdc8b
Pavlov. Cond. change in total contacts	69.48	1	1	3.2	0	1.00e+00	Klhdc8b
Pavlov. Cond. index score	14.07	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. lever-magazine prob. diff.	14.82	1	0	0	0	1.00e+00	Klhdc8b
Bone: apparent density	12.01	6	0	0	1	2.48e-19	Fry Hmgb1 Katnal1 LOC102549494 LOC102553253 Rxfp2
Bone surface	11.81	4	0	0	1	4.71e-16	Fry LOC102549494 Rxfp2 Snapc2
Bone volume	11.59	4	0	0	0.99	1.09e-07	Cacul1 Hmgb1 LOC102549494 LOC102553253
Bone: connectivity density	13.7	6	1	3.2	1	2.96e-19	Fry LOC102549494 LOC120095830 LOC120095871 Rxfp2 Snapc2
Bone: cortical area	14.22	11	0	0	1	1.70e-39	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: cortical porosity	16.96	1	0	0	0	1.00e+00	LOC103694460
Bone: cortical thickness	11.55	6	0	0	-0.03	9.48e-01	Emx2os Fam204a LOC120100068 Prlhr Rab11fip2 Zfp950
Bone: endosteal perimeter	25.18	1	1	3.2	0	1.00e+00	LOC103694460
Bone: final force	11.23	6	0	0	1	1.21e-12	Cacul1 Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: final moment	11.73	6	0	0	1	3.58e-19	Cacul1 Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: maximum diameter	23.35	1	1	3.2	0	1.00e+00	LOC103694460
Bone: maximum force	10.64	6	0	0	1	2.74e-10	Cacul1 Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: maximum moment	11.11	6	0	0	1	3.98e-12	Cacul1 Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: minimum diameter	9.28	2	0	0	0	1.00e+00	Cacul1 LOC103694460
Bone: periosteal estimation	9.62	9	0	0	1	2.80e-27	Cacul1 Dennd10 Emx2os Fam204a Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: periosteal perimeter	12.04	9	0	0	0.99	3.21e-26	Cacul1 Ces2c Dennd10 Grk5 LOC102550729 LOC103694460 Prlhr Sfxn4 Zfp950
Bone: stiffness	13.41	1	0	0	0	1.00e+00	Klhdc8b
Bone: trabecular number	12.38	1	0	0	1	3.69e-08	LOC102549494
Bone: trabecular thickness	15.76	5	0	0	1	9.51e-11	Cacul1 Grk5 Prlhr Sfxn4 Zfp950
Distance traveled before self-admin	50.41	1	1	3.2	0	1.00e+00	Zdhhc1
Delta time in open arm before/after self-admin	26.67	1	0	0	0	1.00e+00	Zfand2b
Active lever presses in extinction session 6	26.41	1	0	0	0	1.00e+00	Zfand2b
Delta ambulatory time before/after self-admin	16.57	1	0	0	0	1.00e+00	Zdhhc1
Time in closed arm before self-admin	44.32	1	1	3.2	0	1.00e+00	Zfand2b
Time in open arm before self-admin	24.67	1	0	0	0	1.00e+00	Zfand2b
Time to tail flick, vehicle, before self-admin	18.85	1	0	0	0	1.00e+00	Zdhhc1
Time to tail flick, vehicle, after self-admin	56.6	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Delta time to tail flick, vehicle, before/after SA	74.6	1	1	3.2	0	1.00e+00	Zfand2b
Ambulatory time before self-admin	29.88	2	1	3.2	0	1.00e+00	Zdhhc1 Zfand2b
Total heroin consumption	18.89	1	0	0	0	1.00e+00	Klhdc8b
Area under the delay curve	31.15	1	1	3.2	0	1.00e+00	Zfand2b
Delay disc. indifference point, 0s delay	28.7	1	1	3.2	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 16s delay	69.03	1	1	3.2	0	1.00e+00	Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	41.82	1	1	3.2	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 8s delay	74.24	1	1	3.2	0	1.00e+00	Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	96.73	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Time >=10cm from walls, locomotor time 1	79.04	1	1	3.2	0	1.00e+00	Zfand2b
Rest time, locomotor task time 1	22.55	1	0	0	0	1.00e+00	Klhdc8b
Distance moved, locomotor task time 1	31.01	1	1	3.2	0	1.00e+00	Klhdc8b
Vertical activity count, locomotor time 1	73.36	2	2	6.5	0	1.00e+00	Klhdc8b Zfand2b
Bouts of movement, locomotor time 2	21.88	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Total resting periods, locomotor time 2	28.25	2	1	3.2	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 2	28.62	3	2	6.5	0	1.00e+00	Klhdc8b Zdhhc1 Zfand2b
Distance moved, locomotor task time 2	48.07	3	2	6.5	0	1.00e+00	Klhdc8b Zdhhc1 Zfand2b
Vertical activity count, locomotor time 2	54.92	1	1	3.2	0	1.00e+00	Klhdc8b
Weight adjusted by age	30.32	1	1	3.2	0	1.00e+00	Klhdc8b
Progressive ratio	22.47	1	0	0	0	1.00e+00	Zdhhc1
Food seeking constrained by brief footshock	14.98	1	0	0	0	1.00e+00	Zfand2b
Run reversals in cocaine runway, females	36.45	1	1	3.2	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway	34.23	1	1	3.2	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	3.2	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, M	42.07	1	1	3.2	0	1.00e+00	Zdhhc1
Cd content in liver	20.17	1	0	0	0	1.00e+00	Klhdc8b
Cu content in liver	43.87	1	1	3.2	0	1.00e+00	LOC103694460
Fe content in liver	33.68	2	2	6.5	0	1.00e+00	Klhdc8b LOC103694460
K content in liver	46.75	1	1	3.2	0	1.00e+00	LOC103694460
Na content in liver	16.36	1	0	0	0	1.00e+00	Klhdc8b
Rb content in liver	66.6	2	2	6.5	0	1.00e+00	Klhdc8b LOC103694460
Sr content in liver	22.32	2	0	0	0	1.00e+00	Klhdc8b LOC103694460

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	19	0.5	2.74
Adipose	alternative TSS	30	0.9	2.93
Adipose	gene expression	52	0.6	2.7
Adipose	isoform ratio	22	0.5	2.78
Adipose	intron excision ratio	17	0.5	2.73
Adipose	mRNA stability	24	0.5	2.61
BLA	alternative polyA	8	0.4	2.88
BLA	alternative TSS	14	0.7	3.08
BLA	gene expression	44	0.7	2.78
BLA	isoform ratio	19	0.6	2.89
BLA	intron excision ratio	28	0.8	2.9
BLA	mRNA stability	17	0.7	2.85
Brain	alternative polyA	22	0.6	2.64
Brain	alternative TSS	24	0.6	2.96
Brain	gene expression	47	0.5	2.71
Brain	isoform ratio	40	0.7	2.85
Brain	intron excision ratio	38	0.6	2.76
Brain	mRNA stability	33	0.6	2.76
Eye	alternative polyA	0	0	3.38
Eye	alternative TSS	6	1.5	3.11
Eye	gene expression	11	0.9	3.03
Eye	isoform ratio	5	0.9	3.07
Eye	intron excision ratio	7	0.8	2.58
Eye	mRNA stability	4	1.1	3.21
IL	alternative polyA	2	0.2	2.93
IL	alternative TSS	2	0.3	2.59
IL	gene expression	26	0.6	2.79
IL	isoform ratio	7	0.6	2.77
IL	intron excision ratio	11	1	3.06
IL	mRNA stability	5	0.4	2.72
LHb	alternative polyA	1	0.1	2.72
LHb	alternative TSS	4	0.7	3.07
LHb	gene expression	32	0.9	2.86
LHb	isoform ratio	5	0.4	2.84
LHb	intron excision ratio	13	1.1	2.87
LHb	mRNA stability	7	0.6	2.82
Liver	alternative polyA	14	0.5	2.68
Liver	alternative TSS	18	0.7	2.79
Liver	gene expression	29	0.4	2.63
Liver	isoform ratio	18	0.5	2.7
Liver	intron excision ratio	24	0.5	2.64
Liver	mRNA stability	19	0.6	2.83
NAcc	alternative polyA	14	0.5	2.83
NAcc	alternative TSS	17	0.6	2.94
NAcc	gene expression	54	0.6	2.83
NAcc	isoform ratio	28	0.7	2.84
NAcc	intron excision ratio	40	0.8	3.04
NAcc	mRNA stability	22	0.7	2.88
OFC	alternative polyA	0	0	2.77
OFC	alternative TSS	10	1.4	3.26
OFC	gene expression	22	0.5	2.92
OFC	isoform ratio	9	0.7	2.83
OFC	intron excision ratio	7	0.6	2.89
OFC	mRNA stability	2	0.1	2.72
PL	alternative polyA	13	0.4	2.76
PL	alternative TSS	25	0.8	2.95
PL	gene expression	45	0.5	2.76
PL	isoform ratio	26	0.5	2.85
PL	intron excision ratio	40	0.7	2.96
PL	mRNA stability	27	0.7	2.79
pVTA	alternative polyA	7	0.4	2.88
pVTA	alternative TSS	10	0.7	3.18
pVTA	gene expression	40	0.8	2.84
pVTA	isoform ratio	21	0.9	3.01
pVTA	intron excision ratio	26	0.9	2.97
pVTA	mRNA stability	7	0.5	2.75
RMTg	alternative polyA	2	0.3	2.59
RMTg	alternative TSS	1	0.2	2.98
RMTg	gene expression	13	0.7	2.7
RMTg	isoform ratio	5	0.8	3.03
RMTg	intron excision ratio	11	1.4	2.94
RMTg	mRNA stability	4	0.6	2.48